Major CD4 epitopes involved in anti-CD4 T-cell autoimmunity in HIV-1 patients

Vaccine

Volumn 25, Issue 16 SPEC. ISS., 2007, Pages 3192-3199

  Abulafia Lapid, Rivka ^a   Keren Zur, Yael ^a   Yachnin, Yulia ^a   Atlan, Henri ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Anti CD4 autoimmunity; HIV 1; Human CD4; Immunogenic epitopes; T cell vaccination

Indexed keywords

CD4 ANTIGEN; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; SYNTHETIC PEPTIDE;

ADULT; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

EID: 33947600285     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.040     Document Type: Article

References (11)

1. Pantaleo G., and Fauci A.S. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 13 (1995) 487-512
2. Zarling J.M., Ledbetter J.A., Sias J., Fultz P., Eichberg J., Gjerset G., et al. HIV-infected humans but not chimpanzees have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. J Immunol 144 (1990) 2992-2998
3. Israel-Biet D., Venet A., Beldjord K., Andrieu J.M., and Even P. Autoreactive cytotoxicity in HIV-infected individuals. Clin Exp Immunol 81 (1990) 18-24
4. Kaufmann G.R., Perrin L., Pantaleo G., Opravil M., Furre H., Telenti A., et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med 163 18 (2003) 2187-2195
5. Caporossi A.P., Bruno G., Salemi S., Mastroianni C., Falciano M., Salotti A., et al. Autoimmune T-cell response to the CD4 molecule in HIV-infected patients. Virol Immunol 11 (1998) 9-17
6. Abulafia-Lapid R., Mayan S., Bentwich Z., Keren-Zur Y., Abramovitz J., Cohen I.R., et al. T-cell vaccination against anti-CD4 autoimmunity in HIV-1 subtypes B and C-infected patients-an extended open trial. Vaccine 23 (2005) 2149-2153
7. Zhang J. T cell vaccination as an immunotherapy for autoimmune disease. Cell Mol Immunol 1 5 (2004) 321-327
8. Atlan H., and Cohen I.R. T-cell vaccination for HIV-seropositive patients. In: Gupta S. (Ed). Immunology of HIV Infection (1996), Plenum Press, New York 535-559
9. Mizukami T.R., Fuerst T.R., Berger E.A., and Moss B. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecules defined by site-directed mutagenesis. Proc Natl Acad Sci USA 85 23 (1988 December) 9273-9277
10. Salemi S., Caporossi A.P., Boffa L., Longobardi M.G., and Barnaba V. HIV gp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J Exp Med 181 (1995) 2253-2257
11. Denisova G., Lideman L., Spectorman E., Abulafia-Lapid R., Burke M., Yust I., et al. Characterization of new monoclonal antibodies that discriminate between soluble and membrane CD4 and compete with human anti-CD4 autoimmune sera. Mol Immunol 40 (2003) 231-239